Semaglutide Heals Liver Directly, Not Via Weight Loss
New 2026 study reveals semaglutide improves liver health by acting directly on liver cells — independent of weight loss. Learn what this means for ...
#Semaglutide #Ozempic #Wegovy #LiverHealth #GLP1
https://scrollworthy.org/trending/semaglutide
Hoth Therapeutics' Groundbreaking HT-VA Study Shows GDNF Outperforms Semaglutide for Liver Fat Reprogramming #United_States #New_York #Semaglutide #Hoth_Therapeutics #GDNF
AI analysis of social media posts reveals potential side effects of GLP-1 meds that researchers say may not be fully captured in clinical trials.
youtu.be/1h-dr9VBs20
#semaglutide #tirzepatide #ozempic #mounjaro #wegovy #zepbound #GLP1 #GLP1drugs
#MedNews - Two phase 3 studies have shown that oral #semaglutide does not slow disease progression in people with early #AlzheimerDisease.
Full story 👉 buff.ly/yup7n2B
#NeuroSky
🧬 Genetics may influence the effectiveness of weight loss drugs, study finds 🧬
Read the full story here: buff.ly/QXFMsqx
#GLP1 #weightloss #genetics #semaglutide #tirzepatide #efficacy #outcomes
Dysaesthesia has been included on the list of possible adverse reactions to semaglutide
#dysaesthesia #semaglutide #Rybelsus #ADRs
buff.ly/n4YUerS
23andMe study finds common gene variants modestly affect weight loss and nausea on GLP‑1 drugs
agentictribune.com/article/2026...
#genetics #glp1 #23andme #weightloss #semaglutide
Half-dozen Indian drugmakers have launched generic #semaglutide, with 40+ expected to follow. The cheapest version costs $14 a month. The drug goes for as much as $349 a month in the US without insurance (where patents last until 2032).
In a new case report in JCP, #semaglutide, a #GLP-1 receptor agonist, was associated with sustained remission of gambling behavior in a patient with #gambling disorder. This case highlights a potential new pharmacologic pathway targeting reward systems.
🔗 Read more: journals.lww.com/psychopharma...
Line graphs show mean blood pressure values over time. The SBP graph shows placebo decreasing slightly while oral semaglutide increases. The DBP graph shows both decreasing, with oral semaglutide slightly lower. The PP graph shows placebo steady, oral semaglutide increasing.
#Type2Diabetes patients at high cardiovascular risk receiving oral #semaglutide demonstrated early and sustained improvements in glycated hemoglobin, body weight, systolic blood pressure, and lipid profiles vs placebo.
ja.ma/47JFQTG
More than a million patients who have had a heart attack or stroke and are overweight will now be eligible for weight loss jabs on the NHS after a new NICE technology appraisal recommended their use.
#NICE #WeightLoss #Semaglutide
Tired of the "yo-yo" diet cycle? Reach your goals with Semaglutide Weight Loss at Elite Women’s Care. Experience a medically supervised, FDA-approved approach to sustainable weight loss.
🔗 elitewomencare.com/shop
#WeightLoss #Semaglutide #elitewomenscare #HealthyLifestyle
JAMA Research Letter, published April 2, 2026, titled "Medicare Spending Implications for Semaglutide Under Voluntary Price Agreements." Table 1 shows coverage and cost sharing for semaglutide injectables under Medicare Part D, 2023-2026.
From @jama.com: At a $245/month price, the CMS BALANCE model could save Medicare nearly $933 million on #semaglutide in 2027, offsetting costs for up to 550 000 additional beneficiaries eligible for #obesity coverage.
ja.ma/4coKTLP
JAMA Research Letter, published April 2, 2026, titled "Medicare Spending Implications for Semaglutide Under Voluntary Price Agreements." Table 1 shows coverage and cost sharing for semaglutide injectables under Medicare Part D, 2023-2026.
From @jama.com: At a $245/month price, the CMS BALANCE model could save Medicare nearly $933 million on #semaglutide in 2027, offsetting costs for up to 550 000 additional beneficiaries eligible for #obesity coverage.
ja.ma/4c88lf2
A research letter from JAMA, published online April 2, 2026, titled "Medicare Spending Implications for Semaglutide Under Voluntary Price Agreements." Table 1 shows coverage and cost sharing per fill for semaglutide injectables under Medicare Part D, 2023-2026.
At a $245/month price, the CMS BALANCE model could save Medicare nearly $933 million on #semaglutide in 2027, offsetting costs for up to 550 000 additional beneficiaries eligible for #obesity coverage.
ja.ma/4dqkQoL
A research letter from JAMA titled "Medicare Spending Implications for Semaglutide Under Voluntary Price Agreements" includes a table showing the coverage and cost sharing per fill for semaglutide injectables under Medicare Part D from 2023-2026.
At a $245/month price, the CMS BALANCE model could save Medicare nearly $933 million on #semaglutide in 2027, offsetting costs for up to 550 000 additional beneficiaries eligible for #obesity coverage.
ja.ma/4c7C0VL
GESPOT - Britse wereldpremière: afslankmiddel vergoed tegen risico op hart- en vaatziekten www.foodlog.nl/gespot/2026-... #vk #ozempic #wegovy #afslankmiddelen #semaglutide #hartenvaatziekten #grootbrittannie #nhs
Semaglutide can reduce body weight by up to 14.9% in clinical trials.
livingdiabetes.com
#LivingDiabetes #Semaglutide #WeightLoss
Ozempic vs Wegovy vs Rybelsus: Comparative Analysis (2026) Semaglutide, known by the brand names Ozempic, Wegovy, Rybelsus and others, is the latest weight-loss craze to hit Hollywood and beyond. T...
#diabetes #mellitus #GLP-1 #pharma #semaglutide #weight #loss
Origin | Interest | Match
Some weight loss medicines may reduce risk of worsening mental illness, study suggests
Read it here 👉️ buff.ly/Z85KDy7
#GLP1 #mentalhealth #depression #anxiety #semaglutide #treatment
The Disappearing Benefits of GLP-1 Drugs
The weight-loss and heart benefits of GLP-1 RA drugs like Ozempic build over time. They also fade if the medication is stopped. www.thedoctorwillseeyounow.com/content/hear... @bmjmedicine.bsky.social #cardio #zepbound #tirzepatide #semaglutide #cvd #GLP
Novo Nordisk’s higher-dose semaglutide arrives fast, but the bigger story is what it signals for obesity, pricing and the longevity market.
Link as first comment.
#longevity #obesity #semaglutide #biotech #innovation
Line graphs show mean blood pressure values over time. Graph A: SBP for placebo, the value decreases slightly from approximately text@134.5 to text@132. Graph B: DBP. Both values decrease to approximately text@74.5. Graph C: PP decreases from text@58 to text@57.5.
#Type2Diabetes patients at high cardiovascular risk receiving oral #semaglutide demonstrated early and sustained improvements in glycated hemoglobin, body weight, systolic blood pressure, and lipid profiles vs placebo.
ja.ma/4lVmHUB
🎊 New drug revolutionising the management of #obesity
✅ New kid on the block
👀 Check out the visual abstract of the #REMODEL trial
#semaglutide
@theisn.org
#ISNWCN
@dilushiwijay.bsky.social @nephroseeker.medsky.social @dramiliflores.bsky.social
12 Best Natural Alternatives to Ozempic for Weight Loss (2026) At a glance Some natural alternatives to Ozempic include berberine, which may help manage blood sugar and support weight loss, along w...
#diabetes #mellitus #GLP-1 #ozempic #pharma #semaglutide #vitamin #and #mineral #weight #loss […]
Line graphs show mean blood pressure values over time. The SBP graph shows placebo decreasing slightly while oral semaglutide increases. The DBP graph shows both decreasing, with oral semaglutide slightly lower. The PP graph shows placebo steady, oral semaglutide increasing.
#Type2Diabetes patients at high cardiovascular risk receiving oral #semaglutide demonstrated early and sustained improvements in glycated hemoglobin, body weight, systolic blood pressure, and lipid profiles vs placebo.
ja.ma/40RRRmk
India Set To Launch Low-Cost Ozempic Copies As Patents Expire
Full Story: indiawest.com/india-set-to...
#OzempicIndia #Semaglutide #GenericDrugs #IndianPharma #AffordableMedicine #DiabetesCare #WeightLossDrugs
Wegovy HD 7.2 mg Pen
FDA approves Wegovy HD, adding semaglutide 7.2 mg for obesity. The key question is what it means in practice for people who respond to 2.4 mg but plateau.
jcst2d.com/index.php/ne...
#ObesityCare #Semaglutide #WegovyHD
A new study finds even brief breaks from GLP-1 medications can increase the risk of heart attack, stroke, and death—highlighting the importance of staying on treatment.
youtu.be/Bx3hOlEcUOQ
#GLP1 #Semaglutide #DiabetesCare #HeartHealth #CardiovascularRisk #WeightLossDrugs
